Preoperative model for predicting prostate specific antigen recurrence after radical prostatectomy using percent of biopsy tissue with cancer, biopsy Gleason grade and serum prostate specific antigen

Journal of Urology

Volumn 171, Issue 6 I, 2004, Pages 2215-2220

  Freedland, Stephen J ^a   Terris, Martha K ^b   Csathy, George S ^c   Kane, Christopher J ^e,f   Amling, Christopher L ^g   Presti Jr , Joseph C ^h   Dorey, Frederick ^d   Aronson, William J ^c,d  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MEDICAL COLLEGE OF GEORGIA   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g NAVAL MEDICAL CENTER SAN DIEGO   (United States)

^h STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Prostate; Prostate specific antigen; Prostatectomy; Prostatic neoplasms; Recurrence

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADOLESCENT; ADULT; CANCER ADJUVANT THERAPY; CANCER GRADING; CANCER RECURRENCE; CANCER RISK; CANCER STAGING; HIGH RISK PATIENT; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NEEDLE BIOPSY; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY; RETROSPECTIVE STUDY; REVIEW;

EID: 2442417691     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ju.0000124463.13319.0a     Document Type: Article

References (20)

1. Kattan, M. W., Eastham, J. A., Stapleton, A. M., Wheeler, T. M. and Scardino, P. T.: A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer. J Natl Cancer Inst, 90: 766, 1998
2. D'Amico, A. V., Whittington, R., Malkowicz, S. B., Schultz, D., Blank, K., Broderick, G. A. et al: Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA, 280: 969, 1998
3. Nelson, C. P., Rubin, M. A., Strawderman, M., Montie, J. E. and Sanda, M. G.: Preoperative parameters for predicting early prostate cancer recurrence after radical prostatectomy. Urology, 59: 740, 2002
4. Presti, J. C., Jr., Shinohara, K., Bacchetti, P., Tigrani, V. and Bhargava, V.: Positive fraction of systematic biopsies predicts risk of relapse after radical prostatectomy. Urology, 52: 1079, 1998
5. D'Amico, A. V., Whittington, R., Malkowicz, S. B., Schultz, D., Fondurulia, J., Chen, M. H. et al: Clinical utility of the percentage of positive prostate biopsies in defining biochemical outcome after radical prostatectomy for patients with clinically localized prostate cancer. J Clin Oncol, 18: 1164, 2000
6. Gretzer, M. B., Epstein, J. I., Pound, C. R., Walsh, P. C. and Partin, A. W.: Substratification of stage T1C prostate cancer based on the probability of biochemical recurrence. Urology, 60: 1034, 2002
7. Ravery, V., Chastang, C., Toublanc, M., Boccon-Gibod, L., Delmas, V. and Boccon-Gibod, L.: Percentage of cancer on biopsy cores accurately predicts extracapsular extension and biochemical relapse after radical prostatectomy for T1-T2 prostate cancer. Eur Urol, 37: 449, 2000
8. Freedland, S. J., Aronson, W. J., Csathy, G. S., Kane, C. J., Amling, C. L., Presti, J. C., Jr. et al: Comparison of percentage of total prostate needle biopsy tissue with cancer to percentage of cores with cancer for predicting PSA recurrence after radical prostatectomy: results from the SEARCH database. Urology, 61: 742, 2003
9. Freedland, S. J., Amling, C. L., Dorey, F., Kane, C. J., Presti, J. C., Jr., Terris, M. K. et al: Race as an outcome predictor after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) Database. Urology, 60: 670, 2002
10. Chan, T. Y., Partin, A. W., Walsh, P. C. and Epstein, J. I.: Prognostic significance of Gleason score 3+4 versus Gleason score 4+3 tumor at radical prostatectomy. Urology, 56: 823, 2000
11. D'Amico, A. V., Cote, K., Loffredo, M., Renshaw, A. A. and Chen, M.-H.: Pretreatment predictors of time to cancer specific death after prostate specific antigen failure. J Urol, 169: 1320, 2003
12. D'Amico, A. V., Whittington, R., Malkowicz, S. B., Fondurulia, J., Chen, M. H., Kaplan, I. et al: Pretreatment nomogram for prostate-specific antigen recurrence after radical prostatectomy or external-beam radiation therapy for clinically localized prostate cancer. J Clin Oncol, 17-168, 1999
13. The SEARCH Database Study Group: Freedland, S. J., Aronson, W. J., Terris, M. K., Kane, C. J., Amling, C. L., Dorey, F. et al: Percent of prostate needle biopsy cores with cancer is significant independent predictor of prostate specific antigen recurrence following radical prostatectomy: results from the SEARCH Database. J Urol, 169: 2136, 2003
14. Partin, A. W., Mangold, L. A., Lamm, D. M., Walsh, P. C., Epstein, J. I. and Pearson, J. D.: Contemporary update of prostate cancer staging nomograms (Partin Tables) for the new millennium. Urology, 58: 843, 2001
15. Pound, C. R., Partin, A. W., Eisenberger, M. A., Chan, D. W., Pearson, J. D. and Walsh, P. C.: Natural history of progression after PSA elevation following radical prostatectomy. JAMA, 281: 1591, 1999
16. Grossfeld, G. D., Latini, D. M., Lubeck, D. P., Broering, J. M., Li, Y., Mehta, S. S. et al: Predicting disease recurrence in intermediate and high-risk patients undergoing radical prostatectomy using percent positive biopsies: results from CaPSURE. Urology, 59: 560, 2002
17. Taneja, S. S., Penson, D. F., Epelbaum, A., Handler, T., Lepor, H. and Jarrard, D. F.: Does site specific labeling of sextant biopsy cores predict the site of extracapsular extension in radical prostatectomy surgical specimen? J Urol, 162: 1352, 1999
18. Tombal, B., Tajeddine, N., Cosyns, J. P., Feyaerts, A., Opsomer, R., Wese, F. X. et al: Does site-specific labelling and individual processing of sextant biopsies improve the accuracy of prostate biopsy in predicting pathological stage in patients with Tlc prostate cancer? BJU Int, 89: 543, 2002
19. Linson, P. W., Lee, A. K., Doytchinova, T., Chen, M. H., Weinstein, M. H., Richie, J. P. et al: Percentage of core lengths involved with prostate cancer: does it add to the percentage of positive prostate biopsies in predicting postoperative prostate-specific antigen outcome for men with intermediate-risk prostate cancer? Urology, 59: 704, 2002
20. Lieberfarb, M. E., Schultz, D., Whittington, R., Malkowicz, B., Tomaszewski, J. E., Weinstein, M. et al: Using PSA, biopsy Gleason score, clinical stage, and the percentage of positive biopsies to identify optimal candidates for prostate-only radiation therapy. Int J Radiat Oncol Biol Phys, 53: 898, 2002